{"database": "lobbying", "table": "lobbying_activities", "rows": [[2180049, "10cb60b3-68d8-4817-9e18-932ce989dd10", "Q3", "AMERICAN UROLOGICAL ASSOCIATION", 90352, "AMERICAN UROLOGICAL ASSOCIATION", 2018, "third_quarter", "MMM", "ensuring appropriate access to Prostate-Specific Antigen screening; equitable implementation of Medicare Access and CHIP Reauthorization Act of 2015", "HOUSE OF REPRESENTATIVES,SENATE", null, 104000, 0, 0, "2018-10-04T13:45:23.287000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2180049"], "units": {}, "query_ms": 144.43645300343633, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}